GSK Investigational Site

Dnipro 49102

0 studies enrolling now · 7 studies all time

What they study most

Asthma, Deep Vein Thrombosis, Epilepsy, Partial, Fibrillation, Atrial, Melanoma, Neoplasms, Breast, Neoplasms, Prostate, Pulmonary Embolism, Thrombocytopaenia, Venous Thromboembolism

Studies at this site

• Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control — Completed
• GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma — Completed
• Odiparcil For The Prevention Of Venous Thromboembolism — Completed
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy — Completed
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed